Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice

K. Mattson*, L. Bosquee, G. Dabouis, A. Le Groumellec, J. L. Pujol, S. Marien, R. Stupp, J. Y. Douillard, B. Brägas, J. Berille, R. Olivares, T. Le Chevalier

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science